Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Resilience19on Feb 09, 2021 2:25pm
208 Views
Post# 32515189

RE:RE:RE:Wow

RE:RE:RE:Wow@monopoly agreed as this represents roughly $25M per quarter and continues to see demand increase. Granted Q4 will have been at a slower pace but if current pace was maintained throughout 2021 (possible given it may even increase) we're looking at roughly $100M in C-19 test revenues for 2021....Nice.
mrmonopoly wrote: Based on the previous sales agreement ($20M over 28wks at 4000kits/wk), that means 12k test/wk comes out to about $2.1M/wk.

My eyes nearly popped out of my head when I heard Marshall say 12000/wk....

Yeehaw1 wrote:

 

MoneyMKR72 wrote: 12000 kits a week

 

 


can someone translate this into some price estimate. 





<< Previous
Bullboard Posts
Next >>